Skip to content

Commit

Permalink
Merge pull request #154 from RConsortium/153-link-summary-of-pilots-a…
Browse files Browse the repository at this point in the history
…nd-pilot-4-blog-post

Update Latest News section of the Pilot3 Website to include the Pharm…
  • Loading branch information
bms63 authored Feb 10, 2024
2 parents 25d143d + 1c72ede commit 4f89a43
Show file tree
Hide file tree
Showing 2 changed files with 7 additions and 0 deletions.
5 changes: 5 additions & 0 deletions README.md
Original file line number Diff line number Diff line change
Expand Up @@ -32,6 +32,11 @@ The website is divide into 4 sections that will walk you through our efforts:
* [Novo Nordisk's Journey to an R based FDA Submission](https://www.youtube.com/watch?v=t33dS17QHuA)
- *Data scientists at Novo Nordisk, a leading pharmaceutical company in diabetes, obesity, and other chronic diseases, share details of their first FDA submission package featuring outputs and* [ADaM datasets](https://www.cdisc.org/standards/foundational/adam) *written exclusively in R.*

\n
* [Testing Containers and WebAssembly in Submissions to the FDA](https://pharmaverse.github.io/blog/posts/2024-02-01_containers_webassembly_submission/containers_and_webassembly_submissions.html)

- *Blog post with short summary of the R Consortium FDA Pilots 1-4 Series and the ongoing efforts undertaken to evaluate new technologies for submissions to the Food and Drug Administration (FDA). These transformative approaches, including WebAssembly and containers, hold immense potential to transform the regulatory landscape and streamline the submission process.*

## Get in Touch

Don't be shy! We like to chat about R and Submissions. Find us on [pharmaverse slack](https://pharmaverse.slack.com/archives/C030EB2M4GM)
2 changes: 2 additions & 0 deletions inst/WORDLIST
Original file line number Diff line number Diff line change
Expand Up @@ -33,9 +33,11 @@ SDTM
Soo
TBW
TLFs
transformative
USUBJID
WG
adam
eCTD
pharmaverse
px
WebAssembly

0 comments on commit 4f89a43

Please sign in to comment.